Discover the Scientific Preliminary Program and Register to the Congress

SOLACI-SOCIME 2022

READ THE PRELIMINARY SCENTIFIC PROGRAM

At SOLACI-SOCIME 2022 you will be able to enjoy -throughout 3 days – simultaneous activities in 4 rooms, a room of edited cases and free topics, and a digital plaza of innovations.

In addition, we will be featuring our traditional satellite ProEducar, Pediatrics and Nurses and Technicians symposia

Register now with 15% off

*Pre-register until Friday, July 22. Past this date, you will be able to register face to face *as of August 3* at Expo Santa Fe

DISCOVER THE SCIENTIIFIC PROGRAM AND SIGN UP NOW!

SOLACI-SOCIME 2022

SOLACI-SOCIME 2022

SOLACI-SOCIME 2022

SOLACI-SOCIME 2022

SOLACI-SOCIME 2022

SOLACI-SOCIME 2022

SOLACI-SOCIME 2022

SOLACI-SOCIME 2022

SOLACI-SOCIME 2022

Register with 15% discount before July 22


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Our webinar “Pulmonary Embolism in 2025: Risk Stratification and Novel Therapeutic Approaches” is now available to watch. The session took place on November 25,...

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

Our webinar “SELUTION: Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives”, held on November 19, 2025 via Zoom with...

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

The Latin American Society of Interventional Cardiology invites you to participate in a new virtual scientific event titled “Pulmonary Embolism (PE) in 2025: Risk...

SELUTION Sirolimus-Eluting Balloon For De Novo Coronary Lesions – New Evidence and Clinical Perspectives

The Latin American Society of Interventional Cardiology invites you to join a new virtual scientific event focused on the latest evidence and clinical perspectives...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

COILSEAL: Use of Coils in Percutaneous Coronary Intervention, Useful for Complication Management?

The use of coils as vascular closing tool has been steadily expanding beyond its traditional role in neuroradiology into coronary territory, where it remains...

Treatment of In-Stent Restenosis in Small Vessels with Paclitaxel-Coated Balloons

Coronary artery disease (CAD) in smaller epicardial vessels occurs in 30% to 67% of patients undergoing percutaneous coronary intervention and poses particular technical challenges....

Contemporary Challenges in Left Atrial Appendage Closure: Updated Approach to Device Embolization

Even though percutaneous left atrial appendage (LAA) closure is generally safe, device embolization – with 0 to 1.5% global incidence – is still a...